Bionano Genomics, Inc. expected to post a loss of 68 cents a share - Earnings Preview

Bionano Genomics

07/08/2026 22:34

Bionano Genomics, Inc. BNGO.OQ BNGO.O is expected to  show a rise in quarterly revenue when it reports  results on August 10 for the period ending June 30 2026
The San Diego California-based  company is expected to report a 11.0% increase in revenue to $7.476 million from $6.73 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.The company's guidance on May 13 2026, for the period ended June 30, was for revenue between $7.50 million and $7.80 million.
​LSEG's mean analyst estimate for Bionano Genomics, Inc. is for a loss of 68 cents per share. 
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for Bionano Genomics, Inc. is $5.00, about 354.5% above its last closing price of $1.10
This summary was machine generated August 7 at 21:34 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)